{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T08:22:56Z","timestamp":1794471776558,"version":"4.9.1"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010843","name":"Guangzhou Science Technology and Innovation Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010096","name":"Southern Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010096","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011480","name":"Foshan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011480","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.ijbiomac.2025.140275","type":"journal-article","created":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T03:29:39Z","timestamp":1737602979000},"page":"140275","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Development of a blocking ELISA for evaluating neutralizing antibodies in human and canine serum based on rabies virus glycoprotein epitope I"],"prefix":"10.1016","volume":"301","author":[{"given":"Haifeng","family":"Mo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanfeng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaming","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bijia","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinlong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiming","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nana","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingsong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailong","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ijbiomac.2025.140275_bb0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004348","article-title":"Rabies virus hijacks and accelerates the p75NTR retrograde axonal transport machinery","volume":"10","author":"Gluska","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ijbiomac.2025.140275_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102819","article-title":"A novel rabies vaccine based on infectious propagating particles derived from hybrid VEEV-rabies replicon","volume":"56","author":"Zhang","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ijbiomac.2025.140275_bb0015","series-title":"Fields Virology","author":"Howley","year":"2022"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.140275_bb0020","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/nrmicro.2018.11","article-title":"The spread and evolution of rabies virus: conquering new frontiers","volume":"16","author":"Fisher","year":"2018","journal-title":"Nat. Rev. Microbiol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.140275_bb0025","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1080\/22221751.2022.2078226","article-title":"Recombinant adeno-associated virus serotype 9 AAV-RABVG expressing a Rabies Virus G protein confers long-lasting immune responses in mice and non-human primates","volume":"11","author":"Shi","year":"2022","journal-title":"Emerg. Microbes Infect."},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.140275_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/v8110279","article-title":"Rabies control and treatment: from prophylaxis to strategies with curative potential","volume":"8","author":"Zhu","year":"2016","journal-title":"Viruses"},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.140275_bb0035","doi-asserted-by":"crossref","first-page":"360","DOI":"10.2471\/BLT.17.194886","article-title":"Rabies control in KwaZulu-Natal, South Africa","volume":"96","author":"LeRoux","year":"2018","journal-title":"Bull. World Health Organ."},{"issue":"38","key":"10.1016\/j.ijbiomac.2025.140275_bb0040","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2020.25.38.1900716","article-title":"Rabies vaccination strategies in the Netherlands in 2018: a cost evaluation","volume":"25","author":"Suijkerbuijk","year":"2020","journal-title":"Euro Surveill."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.140275_bb0045","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1080\/15548627.2016.1196315","article-title":"Wild-type rabies virus induces autophagy in human and mouse neuroblastoma cell lines","volume":"12","author":"Peng","year":"2016","journal-title":"Autophagy"},{"issue":"24","key":"10.1016\/j.ijbiomac.2025.140275_bb0050","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abp9151","article-title":"Structure of the rabies virus glycoprotein trimer bound to a prefusion-specific neutralizing antibody","volume":"8","author":"Callaway","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ijbiomac.2025.140275_bb0055","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1093\/cid\/ciae137","article-title":"Immunogenicity and safety of a purified Vero rabies vaccine - serum free, compared with two licensed vaccines, in a simulated rabies post-exposure regimen in healthy adults in France: a randomized controlled phase 3 trial","author":"Pineda-Pena","year":"2024","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.140275_bb0060","doi-asserted-by":"crossref","first-page":"4080","DOI":"10.1038\/s41467-023-39754-1","article-title":"Author correction: unmodified rabies mRNA vaccine elicits high cross-neutralizing antibody titers and diverse B cell memory responses","volume":"14","author":"Hellgren","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2025.140275_bb0065","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.procbio.2022.11.011","article-title":"Rabies vaccine: recent update and comprehensive review of and studies","volume":"124","author":"Abedi","year":"2023","journal-title":"Process Biochem."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.140275_bb0070","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02435-16","article-title":"Targeting vaccine-induced extrafollicular pathway of B cell differentiation improves rabies postexposure prophylaxis","volume":"91","author":"Haley","year":"2017","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.140275_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.104122","article-title":"Glu in rabies virus glycoprotein is involved in virus attenuation through astrocyte infection and interferon responses","volume":"25","author":"Itakura","year":"2022","journal-title":"Iscience"},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.140275_bb0080","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.neuron.2007.01.033","article-title":"Monosynaptic restriction of transsynaptic tracing from single, genetically targeted neurons","volume":"53","author":"Wickersham","year":"2007","journal-title":"Neuron"},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.140275_bb0085","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1038\/nprot.2013.094","article-title":"Design and generation of recombinant rabies virus vectors","volume":"8","author":"Osakada","year":"2013","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ijbiomac.2025.140275_bb0090","doi-asserted-by":"crossref","DOI":"10.1186\/s12985-017-0789-2","article-title":"Comparison of the protective efficacy between single and combination of recombinant adenoviruses expressing complete and truncated glycoprotein, and nucleoprotein of the pathogenic street rabies virus in mice","volume":"14","author":"Kim","year":"2017","journal-title":"Virol. J."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.140275_bb0095","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.imj.2022.09.003","article-title":"Research progress on neutralizing epitopes and antibodies for the rabies virus","volume":"1","author":"Shi","year":"2022","journal-title":"Infect. Med. (Beijing)"},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.140275_bb0100","doi-asserted-by":"crossref","first-page":"4672","DOI":"10.1128\/JVI.79.8.4672-4678.2005","article-title":"Novel rabies virus-neutralizing epitope recognized by human monoclonal antibody: fine mapping and escape mutant analysis","volume":"79","author":"Marissen","year":"2005","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.140275_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/jvi.62.1.1-7.1988","article-title":"Antigenic site II of the rabies virus glycoprotein: structure and role in viral virulence","volume":"62","author":"Prehaud","year":"1988","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.140275_bb0110","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1128\/jvi.53.3.926-934.1985","article-title":"Rabies virulence: effect on pathogenicity and sequence characterization of rabies virus mutations affecting antigenic site III of the glycoprotein","volume":"53","author":"Seif","year":"1985","journal-title":"J. Virol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.140275_bb0115","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1128\/jvi.65.8.4198-4203.1991","article-title":"Antigenicity of rabies virus glycoprotein","volume":"65","author":"Benmansour","year":"1991","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.140275_bb0120","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/0042-6822(89)90122-0","article-title":"Arginine or lysine in position 333 of ERA and CVS glycoprotein is necessary for rabies virulence in adult mice","volume":"172","author":"Tuffereau","year":"1989","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.140275_bb0125","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1128\/JVI.72.1.273-278.1998","article-title":"An avirulent mutant of rabies virus is unable to infect motoneurons in vivo and in vitro","volume":"72","author":"Coulon","year":"1998","journal-title":"J. Virol."},{"issue":"Suppl. 1","key":"10.1016\/j.ijbiomac.2025.140275_bb0130","doi-asserted-by":"crossref","first-page":"A132","DOI":"10.1016\/j.vaccine.2018.11.004","article-title":"Recent advances in the development of monoclonal antibodies for rabies post exposure prophylaxis: a review of the current status of the clinical development pipeline","volume":"37","author":"Sparrow","year":"2019","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.140275_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008459","article-title":"A next generation vaccine against human rabies based on a single dose of a chimpanzee adenovirus vector serotype C","volume":"14","author":"Napolitano","year":"2020","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.ijbiomac.2025.140275_bb0140","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/4096258","article-title":"Evaluation of in-house ELISA for antirabies antibodies detection in domestic canine","volume":"2023","author":"Fitria","year":"2023","journal-title":"Vet. Med. Int."},{"issue":"44","key":"10.1016\/j.ijbiomac.2025.140275_bb0145","doi-asserted-by":"crossref","first-page":"6565","DOI":"10.1016\/j.vaccine.2023.09.004","article-title":"Evaluation of an iELISA for detection and quantification of rabies antibodies in domestic dog sera","volume":"41","author":"Lugelo","year":"2023","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.140275_bb0150","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jviromet.2011.10.019","article-title":"Evaluation of ELISA for detection of rabies antibodies in domestic carnivores","volume":"179","author":"Wasniewski","year":"2012","journal-title":"J. Virol. Methods"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.140275_bb0155","doi-asserted-by":"crossref","DOI":"10.3390\/v15040874","article-title":"Development and evaluation of an enzyme-linked immunosorbent assay targeting rabies-specific IgM and IgG in human sera","volume":"15","author":"Zajac","year":"2023","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.140275_bb0160","doi-asserted-by":"crossref","first-page":"7288","DOI":"10.1038\/s41598-017-07687-7","article-title":"A time-resolved fluoroimmunoassay to assay the rabies virus glycoprotein: application for estimation of human rabies vaccine potency","volume":"7","author":"Lin","year":"2017","journal-title":"Sci. Rep."},{"issue":"51","key":"10.1016\/j.ijbiomac.2025.140275_bb0165","doi-asserted-by":"crossref","first-page":"7470","DOI":"10.1016\/j.vaccine.2021.10.060","article-title":"A chemiluminescence immunoassay for precise automatic quality control of glycoprotein in human rabies vaccine","volume":"39","author":"Ye","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.ijbiomac.2025.140275_bb0170","first-page":"493","article-title":"A simple method of estimating fifty percent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"The American Journal of Hygiene"},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.140275_bb0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0011770","article-title":"EDIII-Fc induces protective immune responses against the Zika virus in mice and rhesus macaque","volume":"17","author":"Su","year":"2023","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.140275_bb0180","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.03930-22","article-title":"A customized novel blocking ELISA for detection of bat-origin swine acute diarrhea syndrome coronavirus infection","volume":"11","author":"Cao","year":"2023","journal-title":"Microbiol. Spectr."},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.140275_bb0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009980","article-title":"Current characteristics of animal rabies cases in Thailand and relevant risk factors identified by a spatial modeling approach","volume":"15","author":"Thanapongtharm","year":"2021","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.140275_bb0190","first-page":"3","article-title":"Development in immunoprophylaxis against rabies for animals and humans","volume":"2","author":"Nandi","year":"2010","journal-title":"Avicenna J. Med. Biotechnol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.140275_bb0195","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-021-10987-3","article-title":"Knowledge, attitude, and acceptance of healthcare workers and the public regarding the COVID-19 vaccine: a cross-sectional study","volume":"21","author":"Elhadi","year":"2021","journal-title":"BMC Public Health"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.140275_bb0200","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/trstmh\/trab123","article-title":"Rabies and the pandemic: lessons for one health","volume":"116","author":"Nadal","year":"2022","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.140275_bb0205","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1186\/s12917-019-2209-x","article-title":"Detection of rabies antibodies in wild boars in north-east Romania by a rabies ELISA test","volume":"15","author":"Dascalu","year":"2019","journal-title":"BMC Vet. Res."},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.140275_bb0210","doi-asserted-by":"crossref","first-page":"5784","DOI":"10.1073\/pnas.94.11.5784","article-title":"Antigens produced in plants by infection with chimeric plant viruses immunize against rabies virus and HIV-1","volume":"94","author":"Yusibov","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.140275_bb0215","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/s41593-018-0322-y","article-title":"Intersectional monosynaptic tracing for dissecting subtype-specific organization of GABAergic interneuron inputs","volume":"22","author":"Yetman","year":"2019","journal-title":"Nat. Neurosci."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.140275_bb0220","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1099\/0022-1317-40-3-595","article-title":"Immunoglobulin (IgG) and (IgM) antibody responses to rabies vaccine","volume":"40","author":"Turner","year":"1978","journal-title":"J. Gen. Virol."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.140275_bb0225","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1586\/erv.10.105","article-title":"Experimental rabies vaccines for humans","volume":"9","author":"McGettigan","year":"2010","journal-title":"Expert Rev. Vaccines"},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.140275_bb0230","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.5713\/ajas.18.0571","article-title":"Identification of duck liver-expressed antimicrobial peptide 2 and characterization of its bactericidal activity","volume":"32","author":"Hong","year":"2019","journal-title":"Asian Austral J. Anim."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.140275_bb0235","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14091902","article-title":"Expression and evaluation of a novel PPRV nanoparticle antigen based on ferritin self-assembling technology","volume":"14","author":"Li","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijbiomac.2025.140275_bb0240","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jviromet.2016.10.006","article-title":"First international collaborative study to evaluate rabies antibody detection method for use in monitoring the effectiveness of oral vaccination programmes in fox and raccoon dog in Europe","volume":"238","author":"Wasniewski","year":"2016","journal-title":"J. Virol. Methods"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.140275_bb0245","doi-asserted-by":"crossref","first-page":"126","DOI":"10.14202\/vetworld.2019.126-130","article-title":"Serological profiling of rabies antibodies by enzyme-linked immunosorbent assay and its comparative analysis with rapid fluorescent focus inhibition test in mouse model","volume":"12","author":"Debnath","year":"2019","journal-title":"Vet. World"},{"issue":"41","key":"10.1016\/j.ijbiomac.2025.140275_bb0250","doi-asserted-by":"crossref","first-page":"6060","DOI":"10.1016\/j.vaccine.2019.08.043","article-title":"Rabies virus glycoprotein serology ELISA for measurement of neutralizing antibodies in sera of vaccinated human subjects","volume":"37","author":"Zhao","year":"2019","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.140275_bb0255","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1177\/104063879500700109","article-title":"Evaluation of a blocking ELISA using monoclonal antibodies for the detection of porcine epidemic diarrhea virus and its antibodies","volume":"7","author":"Carvajal","year":"1995","journal-title":"J. Vet. Diagn. Investig."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.140275_bb0260","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1099\/jmm.0.006064-0","article-title":"An evaluation of two commercially available ELISAs and one in-house reference laboratory ELISA for the determination of human anti-rabies virus antibodies","volume":"58","author":"Welch","year":"2009","journal-title":"J. Med. Microbiol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.140275_bb0265","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jviromet.2011.10.019","article-title":"Evaluation of ELISA for detection of rabies antibodies in domestic carnivores","volume":"179","author":"Wasniewski","year":"2012","journal-title":"J. Virol. Methods"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025008244?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025008244?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T10:01:15Z","timestamp":1782900075000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025008244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":53,"alternative-id":["S0141813025008244"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.140275","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a blocking ELISA for evaluating neutralizing antibodies in human and canine serum based on rabies virus glycoprotein epitope I","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.140275","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"140275"}}